The risk of a subsequent cancer diagnosis after herpes zoster infection: Primary care database study

Background: Herpes zoster and cancer are associated with immunosuppression. Zoster occurs more often in patients with an established cancer diagnosis. Current evidence suggests some risk of cancer after zoster but is inconclusive. We aimed to assess the risk of cancer following zoster and the impact...

Full description

Bibliographic Details
Main Authors: Cotton, S, Belcher, J, Rose, P, K Jagadeesan, S, Neal, R
Format: Journal article
Language:English
Published: 2013
_version_ 1797050965188149248
author Cotton, S
Belcher, J
Rose, P
K Jagadeesan, S
Neal, R
author_facet Cotton, S
Belcher, J
Rose, P
K Jagadeesan, S
Neal, R
author_sort Cotton, S
collection OXFORD
description Background: Herpes zoster and cancer are associated with immunosuppression. Zoster occurs more often in patients with an established cancer diagnosis. Current evidence suggests some risk of cancer after zoster but is inconclusive. We aimed to assess the risk of cancer following zoster and the impact of prior zoster on cancer survival. Methods: A primary care database retrospective cohort study was undertaken. Subjects with zoster were matched to patients without zoster. Risk of cancer following zoster was assessed by generating hazard ratios using Cox regression. Time to cancer was generated from the index date of zoster diagnosis. Results: In total, 2054 cancers were identified in 74 029 patients (13 428 zoster, 60 601 matches). The hazard ratio for cancer diagnosis after zoster was 2.42 (95% confidence interval 2.21, 2.66) and the median time to cancer diagnosis was 815 days. Hazard ratios varied between cancers, and were highest in younger patients. There were more cancers in patients with zoster than those without for all age groups and both genders. Prior immunosuppression was not associated with change in risk, and diagnosis of zoster before cancer did not affect survival. Conclusion: This study establishes an association between zoster and future diagnosis of cancer having implications for cancer case finding after zoster diagnosis. © 2013 Cancer Research UK. All rights reserved.
first_indexed 2024-03-06T18:13:02Z
format Journal article
id oxford-uuid:03a94b27-d28c-495b-970f-c9efbe206c2a
institution University of Oxford
language English
last_indexed 2024-03-06T18:13:02Z
publishDate 2013
record_format dspace
spelling oxford-uuid:03a94b27-d28c-495b-970f-c9efbe206c2a2022-03-26T08:47:33ZThe risk of a subsequent cancer diagnosis after herpes zoster infection: Primary care database studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:03a94b27-d28c-495b-970f-c9efbe206c2aEnglishSymplectic Elements at Oxford2013Cotton, SBelcher, JRose, PK Jagadeesan, SNeal, RBackground: Herpes zoster and cancer are associated with immunosuppression. Zoster occurs more often in patients with an established cancer diagnosis. Current evidence suggests some risk of cancer after zoster but is inconclusive. We aimed to assess the risk of cancer following zoster and the impact of prior zoster on cancer survival. Methods: A primary care database retrospective cohort study was undertaken. Subjects with zoster were matched to patients without zoster. Risk of cancer following zoster was assessed by generating hazard ratios using Cox regression. Time to cancer was generated from the index date of zoster diagnosis. Results: In total, 2054 cancers were identified in 74 029 patients (13 428 zoster, 60 601 matches). The hazard ratio for cancer diagnosis after zoster was 2.42 (95% confidence interval 2.21, 2.66) and the median time to cancer diagnosis was 815 days. Hazard ratios varied between cancers, and were highest in younger patients. There were more cancers in patients with zoster than those without for all age groups and both genders. Prior immunosuppression was not associated with change in risk, and diagnosis of zoster before cancer did not affect survival. Conclusion: This study establishes an association between zoster and future diagnosis of cancer having implications for cancer case finding after zoster diagnosis. © 2013 Cancer Research UK. All rights reserved.
spellingShingle Cotton, S
Belcher, J
Rose, P
K Jagadeesan, S
Neal, R
The risk of a subsequent cancer diagnosis after herpes zoster infection: Primary care database study
title The risk of a subsequent cancer diagnosis after herpes zoster infection: Primary care database study
title_full The risk of a subsequent cancer diagnosis after herpes zoster infection: Primary care database study
title_fullStr The risk of a subsequent cancer diagnosis after herpes zoster infection: Primary care database study
title_full_unstemmed The risk of a subsequent cancer diagnosis after herpes zoster infection: Primary care database study
title_short The risk of a subsequent cancer diagnosis after herpes zoster infection: Primary care database study
title_sort risk of a subsequent cancer diagnosis after herpes zoster infection primary care database study
work_keys_str_mv AT cottons theriskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT belcherj theriskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT rosep theriskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT kjagadeesans theriskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT nealr theriskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT cottons riskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT belcherj riskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT rosep riskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT kjagadeesans riskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy
AT nealr riskofasubsequentcancerdiagnosisafterherpeszosterinfectionprimarycaredatabasestudy